# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Exane BNP Paribas analyst Kevin Grundy initiates coverage on Keurig Dr Pepper (NASDAQ:KDP) with a Neutral rating and announc...
Truist Securities analyst Bill Chappell upgrades Keurig Dr Pepper (NASDAQ:KDP) from Sell to Hold and raises the price target...
UBS analyst Sean King maintains Keurig Dr Pepper (NASDAQ:KDP) with a Buy and raises the price target from $39 to $40.